PSA testing is a key tool in detecting prostate issues early, but interpreting results requires context. Levels can rise from cancer or other benign conditions, so follow-up tests are often needed.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

PSA concentrations are higher in men who engage in more sedentary behavior and lower levels of light physical activity, a study found. In an analysis of data from the 2003-2004 or 2005-2006 National ...

The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...

Hormonal therapies are effective for recurrent and advanced prostate cancer, with PSA levels crucial for risk stratification. Combination hormone therapy is advised for metastatic prostate cancer, ...

* Higher PSA levels at 65-69 linked to greater prostate cancer mortality after 70 * 80% of prostate cancer deaths after age 70 occurred in men with PSA (and) #8805;2.0 ng/mL //at 65-69 * Low PSA ...

Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...